Urolithin A Exercise Recovery Randomized Trial Evidence Table

Structured evidence table for Urolithin A Exercise Recovery Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Urolithin A Exercise Recovery Randomized TrialWukich and colleagues established that diabetes adversely affects outcomes across all orthopedic subspecialties, including increased surgical site infections, delayed wound healing, and impaired bone consolidation [].4Santos Márcia da Silva (2026)Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
Urolithin A Exercise Recovery Randomized TrialMeta-analytic evidence demonstrates that diabetic patients have an odds ratio of 2.11 for impaired fracture healing compared to non-diabetic individuals [], while tendinopathy prevalence is markedly elevated, with 27.5% of diabetic patients experiencing shoulder disorders compared to 5% in the general population [,].4Santos Márcia da Silva (2026)Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
Urolithin A Exercise Recovery Randomized TrialA notable 19-year follow-up study confirmed a persistent increased risk of tendon injury in patients with structured diabetes care.4Santos Márcia da Silva (2026)Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
Urolithin A Exercise Recovery Randomized Trial1 2 3 4 Type 2 diabetes mellitus (T2DM) has reached pandemic proportions, affecting over 537 million adults globally, with projections indicating 783 million by 2045 [].4Santos Márcia da Silva (2026)Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
topicUrolithin A Exercise Recovery Randomized Trial
claimWukich and colleagues established that diabetes adversely affects outcomes across all orthopedic subspecialties, including increased surgical site infections, delayed wound healing, and impaired bone consolidation [].
evidence level4
citationSantos Márcia da Silva (2026)
sourceNutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
topicUrolithin A Exercise Recovery Randomized Trial
claimMeta-analytic evidence demonstrates that diabetic patients have an odds ratio of 2.11 for impaired fracture healing compared to non-diabetic individuals [], while tendinopathy prevalence is markedly elevated, with 27.5% of diabetic patients experiencing shoulder disorders compared to 5% in the general population [,].
evidence level4
citationSantos Márcia da Silva (2026)
sourceNutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
topicUrolithin A Exercise Recovery Randomized Trial
claimA notable 19-year follow-up study confirmed a persistent increased risk of tendon injury in patients with structured diabetes care.
evidence level4
citationSantos Márcia da Silva (2026)
sourceNutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review
topicUrolithin A Exercise Recovery Randomized Trial
claim1 2 3 4 Type 2 diabetes mellitus (T2DM) has reached pandemic proportions, affecting over 537 million adults globally, with projections indicating 783 million by 2045 [].
evidence level4
citationSantos Márcia da Silva (2026)
sourceNutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review

Source documents

  1. Nutritional Interventions to Optimize Orthobiologic Therapy Quality in Type 2 Diabetes Mellitus: Molecular Mechanisms and Clinical Framework: A Narrative Review